Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does it matter how we lower blood pressure?

Jimmy Stewart1, Marion R Wofford, Deborah S King

  • 1Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi 39216, USA. jstewart@medicine.umsmed.edu

The American Journal of the Medical Sciences
|December 13, 2003
PubMed
Summary

Cardiovascular disease risk in hypertensive patients has fallen due to better hypertension awareness, treatment, and drugs. Further research is needed to understand if drugs offer benefits beyond lowering blood pressure.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Circulation·2026
Same author

Correction to: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Hypertension (Dallas, Tex. : 1979)·2026
Same author

Correction to: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Hypertension (Dallas, Tex. : 1979)·2026
Same author

Correction to: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Circulation·2026
Same author

Bending the Curve in Hypertension Management: It Is Time for a Fundamentally Different Approach.

Journal of the American College of Cardiology·2026
Same author

2026 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association.

Circulation·2026

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Significant decline in cardiovascular disease (CVD) risk among hypertensive patients over the past 40 years.
  • Attributed to increased hypertension awareness, aggressive blood pressure (BP) lowering targets, and improved antihypertensive medications.
  • Emerging evidence suggests potential BP-independent protective effects of certain antihypertensive drug classes.

Framework:

  • Investigating the mechanisms behind CVD risk reduction in hypertension.
  • Evaluating the comparative efficacy of different antihypertensive drug classes.
  • Differentiating between BP-lowering effects and intrinsic pharmacological properties of drugs.

Implementation:

  • Analysis of recent clinical studies and epidemiological data.

Related Experiment Videos

  • Comparative effectiveness research comparing various antihypertensive agents.
  • Biomarker studies to elucidate BP-independent pathways.

    • Implications:

    • Clarifying the role of specific antihypertensive agents in CVD prevention.
    • Informing clinical guidelines for hypertension management.
    • Optimizing pharmacotherapy for hypertensive patients to minimize cardiovascular events.